Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.
J Clin Invest
; 129(12): 5553-5567, 2019 12 02.
Article
in En
| MEDLINE
| ID: mdl-31710313
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Galectin 1
/
Endothelium
/
B7-H1 Antigen
/
Programmed Cell Death 1 Receptor
/
Head and Neck Neoplasms
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Invest
Year:
2019
Document type:
Article